Neovision Capital
33
27M
30
3.67
5
0.09
2
- Stages of investment
- Areas of investment
Summary
Neovision Capital appeared to be the VC, which was created in 2015. The main office of represented VC is situated in the Shanghai. The venture was found in Asia in China.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Neovision Capital, startups are often financed by Shunwei Capital, Redpoint, Ceyuan Ventures. The meaningful sponsors for the fund in investment in the same round are Zhongjin Qichen, Zeyue Capital, Yonyou. In the next rounds fund is usually obtained by Didi Chuxing, Tencent Holdings, PICC Asset Management.
The overall number of key employees were 1.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019.
The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Rimag, Smartee Denti-Technology, RenRenChe. Among the most successful fund investment fields, there are 3D Technology, Cloud Data Services. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
Investments analytics
Analytics
- Total investments
- 33
- Lead investments
- 5
- Exits
- 2
- Rounds per year
- 3.67
- Follow on index
- 0.09
- Investments by industry
- Health Care (12)
- Medical (12)
- Biotechnology (8)
- Information Technology (6)
- Medical Device (6) Show 31 more
- Investments by region
-
- China (32)
- United States (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 13M
- Group Appearance index
- 0.64
- Avg. company exit year
- 16
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Chineo | 01 Oct 2021 | Early Stage Venture | 90M | Beijing, Beijing, China | |
| New Radiomedicine Technology | 14 Mar 2024 | Biotechnology, Health Care, Medical | Late Stage Venture | 46M | Sichuan, Qingyang District, China |
| XenoTherapeutics | 01 Jul 2019 | Biotechnology, Medical Device, Life Science | Seed | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.